The Ninth Annual American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research

Li Xu, Sophia S. Wang, Megan A. Healey, Jessica M. Faupel-Badger, Jason A. Wilken, Tracy Battaglia, Eva Szabo, Jenny T. Mao, Raymond Bergan

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The Ninth Annual AACR Frontiers in Cancer Prevention Research conference was held in Philadelphia in November 7-10, 2010. Its thematic focus was "Prevention: From Basic Science to Public Health Benefit." Telomere plasticity, the microenvironment, inflammation, transformation to the metastatic phenotype, and pathways to obesity were highlighted as important elements of carcinogenesis amenable to intervention. The integration of information from novel technologies related to physical biology, molecular and genetic profiles, and imaging along with behavioral and clinical parameters have advanced risk stratification and early detection. Cancer prevention represents a powerful testing ground for the development of individually tailored intervention and for increasing the efficiency of drug discovery. Advances in clinical trials relate to more efficient design strategies, have shown first-in-human targeting capabilities, and have developed powerful strategies to overcome accrual barriers. Tailored intervention strategies now show high efficacy on large cohorts across several cancer types. These successes are expected to increase.

Original languageEnglish (US)
Pages (from-to)616-621
Number of pages6
JournalCancer Prevention Research
Volume4
Issue number4
DOIs
StatePublished - Apr 2011
Externally publishedYes

Fingerprint

Research
Neoplasms
Molecular Imaging
Telomere
Insurance Benefits
Drug Discovery
Molecular Biology
Carcinogenesis
Public Health
Obesity
Clinical Trials
Inflammation
Technology
Phenotype

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The Ninth Annual American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research. / Xu, Li; Wang, Sophia S.; Healey, Megan A.; Faupel-Badger, Jessica M.; Wilken, Jason A.; Battaglia, Tracy; Szabo, Eva; Mao, Jenny T.; Bergan, Raymond.

In: Cancer Prevention Research, Vol. 4, No. 4, 04.2011, p. 616-621.

Research output: Contribution to journalArticle

Xu, Li ; Wang, Sophia S. ; Healey, Megan A. ; Faupel-Badger, Jessica M. ; Wilken, Jason A. ; Battaglia, Tracy ; Szabo, Eva ; Mao, Jenny T. ; Bergan, Raymond. / The Ninth Annual American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research. In: Cancer Prevention Research. 2011 ; Vol. 4, No. 4. pp. 616-621.
@article{29c036d99b614207b1f74d533bb459a7,
title = "The Ninth Annual American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research",
abstract = "The Ninth Annual AACR Frontiers in Cancer Prevention Research conference was held in Philadelphia in November 7-10, 2010. Its thematic focus was {"}Prevention: From Basic Science to Public Health Benefit.{"} Telomere plasticity, the microenvironment, inflammation, transformation to the metastatic phenotype, and pathways to obesity were highlighted as important elements of carcinogenesis amenable to intervention. The integration of information from novel technologies related to physical biology, molecular and genetic profiles, and imaging along with behavioral and clinical parameters have advanced risk stratification and early detection. Cancer prevention represents a powerful testing ground for the development of individually tailored intervention and for increasing the efficiency of drug discovery. Advances in clinical trials relate to more efficient design strategies, have shown first-in-human targeting capabilities, and have developed powerful strategies to overcome accrual barriers. Tailored intervention strategies now show high efficacy on large cohorts across several cancer types. These successes are expected to increase.",
author = "Li Xu and Wang, {Sophia S.} and Healey, {Megan A.} and Faupel-Badger, {Jessica M.} and Wilken, {Jason A.} and Tracy Battaglia and Eva Szabo and Mao, {Jenny T.} and Raymond Bergan",
year = "2011",
month = "4",
doi = "10.1158/1940-6207.CAPR-11-0018",
language = "English (US)",
volume = "4",
pages = "616--621",
journal = "Cancer Prevention Research",
issn = "1940-6207",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - The Ninth Annual American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research

AU - Xu, Li

AU - Wang, Sophia S.

AU - Healey, Megan A.

AU - Faupel-Badger, Jessica M.

AU - Wilken, Jason A.

AU - Battaglia, Tracy

AU - Szabo, Eva

AU - Mao, Jenny T.

AU - Bergan, Raymond

PY - 2011/4

Y1 - 2011/4

N2 - The Ninth Annual AACR Frontiers in Cancer Prevention Research conference was held in Philadelphia in November 7-10, 2010. Its thematic focus was "Prevention: From Basic Science to Public Health Benefit." Telomere plasticity, the microenvironment, inflammation, transformation to the metastatic phenotype, and pathways to obesity were highlighted as important elements of carcinogenesis amenable to intervention. The integration of information from novel technologies related to physical biology, molecular and genetic profiles, and imaging along with behavioral and clinical parameters have advanced risk stratification and early detection. Cancer prevention represents a powerful testing ground for the development of individually tailored intervention and for increasing the efficiency of drug discovery. Advances in clinical trials relate to more efficient design strategies, have shown first-in-human targeting capabilities, and have developed powerful strategies to overcome accrual barriers. Tailored intervention strategies now show high efficacy on large cohorts across several cancer types. These successes are expected to increase.

AB - The Ninth Annual AACR Frontiers in Cancer Prevention Research conference was held in Philadelphia in November 7-10, 2010. Its thematic focus was "Prevention: From Basic Science to Public Health Benefit." Telomere plasticity, the microenvironment, inflammation, transformation to the metastatic phenotype, and pathways to obesity were highlighted as important elements of carcinogenesis amenable to intervention. The integration of information from novel technologies related to physical biology, molecular and genetic profiles, and imaging along with behavioral and clinical parameters have advanced risk stratification and early detection. Cancer prevention represents a powerful testing ground for the development of individually tailored intervention and for increasing the efficiency of drug discovery. Advances in clinical trials relate to more efficient design strategies, have shown first-in-human targeting capabilities, and have developed powerful strategies to overcome accrual barriers. Tailored intervention strategies now show high efficacy on large cohorts across several cancer types. These successes are expected to increase.

UR - http://www.scopus.com/inward/record.url?scp=79955854248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955854248&partnerID=8YFLogxK

U2 - 10.1158/1940-6207.CAPR-11-0018

DO - 10.1158/1940-6207.CAPR-11-0018

M3 - Article

VL - 4

SP - 616

EP - 621

JO - Cancer Prevention Research

JF - Cancer Prevention Research

SN - 1940-6207

IS - 4

ER -